Medium impact
Diabetic Neuropathy: Selected Treatments (CPB 0729, reviewed 2026-10-21)
Aetna·Identified Oct 25, 2026
HCPCS C9254 is officially defined as "Injection, lacosamide, 1 mg." HCPCS C9254 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS C9254 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.